These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein. Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470 [TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. Patel JV; Lim HS; Varughese GI; Hughes EA; Lip GY Ann Med; 2008; 40(3):215-22. PubMed ID: 18382887 [TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Lim HS; Lip GY; Blann AD Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283 [TBL] [Abstract][Full Text] [Related]
14. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Lim HS; Blann AD; Lip GY Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493 [TBL] [Abstract][Full Text] [Related]
15. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients. Nadar S; Blann AD; Lip GY Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942 [TBL] [Abstract][Full Text] [Related]
16. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting. Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155 [TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease. Chang FC; Lai TS; Chiang CK; Chen YM; Wu MS; Chu TS; Wu KD; Lin SL PLoS One; 2013; 8(3):e54668. PubMed ID: 23469160 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. Kurosaka D; Hirai K; Nishioka M; Miyamoto Y; Yoshida K; Noda K; Ukichi T; Yanagimachi M; Furuya K; Takahashi E; Kingetsu I; Fukuda K; Yamada A J Rheumatol; 2010 Jun; 37(6):1121-8. PubMed ID: 20436077 [TBL] [Abstract][Full Text] [Related]
19. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Lip GY; Patel JV; Hughes E; Hart RG Stroke; 2007 Apr; 38(4):1229-37. PubMed ID: 17332453 [TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]